Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...
True expertise is built slowly, through years of dedicated study, self-questioning, and experimentation. The quiet experts – ...
ASX could hit record high despite mixed bag on Wall Street. US stocks expected to outperform bonds as Fed cuts rates.
WASHINGTON - Experts expressed enthusiasm after US health regulators approved the first new form of treatment for ...
Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...
US stocks closed another record-setting week with a muted performance, as hope built on Wall Street that the US economy can ...
Bristol Myers gains FDA approval for a new schizophrenia drug. HHS declares a health emergency in Georgia due to Hurricane ...
U.S. stocks closed another record-setting week with a muted performance Friday, as hope built on Wall Street that the U.S.